Cargando…

Axonal degeneration as a therapeutic target in the CNS

Degeneration of the axon is an important step in the pathomechanism of traumatic, inflammatory and degenerative neurological diseases. Increasing evidence suggests that axonal degeneration occurs early in the course of these diseases and therefore represents a promising target for future therapeutic...

Descripción completa

Detalles Bibliográficos
Autores principales: Lingor, Paul, Koch, Jan C., Tönges, Lars, Bähr, Mathias
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer-Verlag 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3375418/
https://www.ncbi.nlm.nih.gov/pubmed/22392734
http://dx.doi.org/10.1007/s00441-012-1362-3
_version_ 1782235755401183232
author Lingor, Paul
Koch, Jan C.
Tönges, Lars
Bähr, Mathias
author_facet Lingor, Paul
Koch, Jan C.
Tönges, Lars
Bähr, Mathias
author_sort Lingor, Paul
collection PubMed
description Degeneration of the axon is an important step in the pathomechanism of traumatic, inflammatory and degenerative neurological diseases. Increasing evidence suggests that axonal degeneration occurs early in the course of these diseases and therefore represents a promising target for future therapeutic strategies. We review the evidence for axonal destruction from pathological findings and animal models with particular emphasis on neurodegenerative and neurotraumatic disorders. We discuss the basic morphological and temporal modalities of axonal degeneration (acute, chronic and focal axonal degeneration and Wallerian degeneration). Based on the mechanistic concepts, we then delineate in detail the major molecular mechanisms that underlie the degenerative cascade, such as calcium influx, axonal transport, protein aggregation and autophagy. We finally concentrate on putative therapeutic targets based on the mechanistic prerequisites.
format Online
Article
Text
id pubmed-3375418
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Springer-Verlag
record_format MEDLINE/PubMed
spelling pubmed-33754182012-06-18 Axonal degeneration as a therapeutic target in the CNS Lingor, Paul Koch, Jan C. Tönges, Lars Bähr, Mathias Cell Tissue Res Review Degeneration of the axon is an important step in the pathomechanism of traumatic, inflammatory and degenerative neurological diseases. Increasing evidence suggests that axonal degeneration occurs early in the course of these diseases and therefore represents a promising target for future therapeutic strategies. We review the evidence for axonal destruction from pathological findings and animal models with particular emphasis on neurodegenerative and neurotraumatic disorders. We discuss the basic morphological and temporal modalities of axonal degeneration (acute, chronic and focal axonal degeneration and Wallerian degeneration). Based on the mechanistic concepts, we then delineate in detail the major molecular mechanisms that underlie the degenerative cascade, such as calcium influx, axonal transport, protein aggregation and autophagy. We finally concentrate on putative therapeutic targets based on the mechanistic prerequisites. Springer-Verlag 2012-03-06 2012 /pmc/articles/PMC3375418/ /pubmed/22392734 http://dx.doi.org/10.1007/s00441-012-1362-3 Text en © The Author(s) 2012 https://creativecommons.org/licenses/by/4.0/ This article is distributed under the terms of the Creative Commons Attribution License which permits any use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.
spellingShingle Review
Lingor, Paul
Koch, Jan C.
Tönges, Lars
Bähr, Mathias
Axonal degeneration as a therapeutic target in the CNS
title Axonal degeneration as a therapeutic target in the CNS
title_full Axonal degeneration as a therapeutic target in the CNS
title_fullStr Axonal degeneration as a therapeutic target in the CNS
title_full_unstemmed Axonal degeneration as a therapeutic target in the CNS
title_short Axonal degeneration as a therapeutic target in the CNS
title_sort axonal degeneration as a therapeutic target in the cns
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3375418/
https://www.ncbi.nlm.nih.gov/pubmed/22392734
http://dx.doi.org/10.1007/s00441-012-1362-3
work_keys_str_mv AT lingorpaul axonaldegenerationasatherapeutictargetinthecns
AT kochjanc axonaldegenerationasatherapeutictargetinthecns
AT tongeslars axonaldegenerationasatherapeutictargetinthecns
AT bahrmathias axonaldegenerationasatherapeutictargetinthecns